or Try an Advanced Search...

    ETF Components for EFA - iShares MSCI EAFE ETF


    Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

    Holdings

    Symbol Grade Price % Change Allocation
    NVO D 2.37 2.14
    NVS D 0.41 1.28
    TM D 0.59 1.08

    Represented by ETF Holdings

    Keywords: Active Pharmaceutical Ingredients Animal Health Anti Diabetic Drugs Antibiotics Auto Parts Automotive Industry Biopharmaceutical Biotechnology Blood Test Cars Contact Lens Contact Lenses Diabetes Diabetes Care Diagnostic Products Disposable Product Disposable Products Drugs E Commerce Marketplace Endocrine System
    Industries: Auto Manufacturers Biotechnology Drug Manufacturers - Major

    Recent News for iShares MSCI EAFE ETF & its Holdings

    Date Stock Title
    Nov 22 NVS Pharma Stock Roundup: EU Nod for PFE's Hympavzi, NVS Ups Sales View
    Nov 22 NVS Novartis Raises Sales Outlook for Mid-Term, Acquires Kate Therapeutics
    Nov 22 NVO “No magic wand” for Novo Nordisk, as CagriSema pen supply rumours swirl
    Nov 22 NVO Novo Nordisk Plunges 25% in 3 Months: How to Play the Stock
    Nov 22 NVO Barclays says buy Novo Nordisk stock 'into this critically important catalyst'
    Nov 22 NVO RFK Jr. Spooks Weight-Loss Stocks. Should Eli Lilly, Novo Nordisk Be Worried?
    Nov 22 NVO Novo Nordisk said to have contracted Ypsomed to make next gen obesity drug’s pens
    Nov 22 NVS Novartis provides updates to mid-term guidance, now sees 6% sales CAGR 2023-2028
    Nov 22 NVO Oura rings to track blood sugar, Vaccines vs RFK Jr., and Ozempic 2.0: Pharma news roundup
    Nov 22 NVS Novartis acquires Kate Therapeutics to advance gene therapies
    Nov 21 NVO The FDA Can’t Decide Whether Zepbound Is in Shortage. It’s Good News for Hims & Hers Stock.
    Nov 21 NVO Eli Lilly Stock Tumbles As Kennedy Targets Weight Loss Drugs
    Nov 21 NVS Novartis Elevates Midterm Sales Forecast, CEO Highlights Robust Pipeline
    Nov 21 NVS Novartis buys gene therapy developer Kate for up to $1.1B
    Nov 21 TM Experts: These 5 Car Brands Are the Cheapest To Maintain
    Nov 21 TM Toyota Releases 2024 North American Environmental Sustainability Report
    Nov 21 NVO Pfizer Secures Approval for Hemophilia Drug Hympavzi in the EU
    Nov 21 NVS Novartis raises mid-term sales guidance
    Nov 21 NVS Novartis Lifts Midterm Sales Guidance Amid U.S. Expansion
    Nov 21 NVS Novartis wagers more than $1B on gene therapies for the nervous system
    The investment seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the MSCI EAFE® Index (the "underlying index"). The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. The underlying index has been developed by MSCI Inc. ("MSCI") as an equity benchmark for its international stock performance. The underlying index includes stocks from Europe, Australasia and the Far East and, as of June 30, 2012, consisted of the following 22 developed market country indexes or regions.
    Exchange Traded Fund ETF MSCI EAFE
    Back to the Main EFA Page...